For several years, this healthcare system struggled to find a sustainable program to perform outreach to patients with outstanding orders for lung, breast, and colon cancer screenings. A financial analysis of associated expenses, reimbursement, payer mixture, and downstream revenue of these screening efforts demonstrated positive net return on investment, allowing for expansion and implementation of the Population Health Support Services team to perform this task. In 2022, 12 outreach specialists scheduled visits that accounted for 38% of completed lung cancer screenings and 15% of completed breast cancer screenings for this healthcare system.
Cancer screening plays a pivotal role in our approach to delivering comprehensive cancer care. Early detection through screening significantly improves the chances of survival and reduces the burden of cancer on individuals and communities.
